Health

Delivering chemotherapy to colon cancer patients before and after surgery — instead of just after — reduces their risk of recurrence by 28%.

Using spiraling ultrasound waves, researchers hope to remove stroke-causing blood clots faster and safer.

A microbiome-friendly method of controlling Staph colonization has aced phase 2 clinical trials.

Researchers have engineered bacteria to create a “living medicine” against a nasty respiratory bug.

Researchers concluded that exercise should be prescribed to patients with mental health issues before psychiatric drugs.

Alto Neuroscience’s depression drug seems effective in early trials, a proof-of-concept for biomarker-based design.

BioNTech is sending a modular mRNA vaccine factory that can produce 50 million COVID-19 vaccines annually to Africa.

Researchers set out to find the least amount of walking one could do to offset the harmful health effects of sitting.

The device performs similarly to its commercial counterparts but costs one-tenth the price.

Moderna’s mRNA RSV vaccine for adults looks to be over 80% effective, based on early data from a large phase 3 trial.

A new delivery method for mRNA therapies could open the doors to better treatments for aging, cancer, and more.

A “morning after” antiviral nasal spray could be created using new knowledge about how SARS-CoV-2 invades your nose.

After a monumental year of breakthroughs, scientists, investors, and CEOs share which areas of biotech they are eagerly watching this year.

Sections

Video

Freethink

We focus on solutions: the smartest people, the biggest ideas, and the most ground breaking technology shaping our future.